“Lastly, skip the dividend. As much as I would l
Post# of 148292
Agreed. The idea of a dividend for shareholders in growing biotech is ridiculous. Take every penny and focus on enrolling the cancer and NASH trials, while also bringing more experts on board to design top notch phase 2 trials for other conditions. I don’t need the .25 dividend from NP.